Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3953386rdf:typepubmed:Citationlld:pubmed
pubmed-article:3953386lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3953386lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:3953386lifeskim:mentionsumls-concept:C0002598lld:lifeskim
pubmed-article:3953386lifeskim:mentionsumls-concept:C0041017lld:lifeskim
pubmed-article:3953386lifeskim:mentionsumls-concept:C0429028lld:lifeskim
pubmed-article:3953386lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:3953386lifeskim:mentionsumls-concept:C0057522lld:lifeskim
pubmed-article:3953386lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:3953386pubmed:issue4lld:pubmed
pubmed-article:3953386pubmed:dateCreated1986-4-18lld:pubmed
pubmed-article:3953386pubmed:abstractTextThe interrelationships between serum levels of amiodarone, desethylamiodarone, and reverse T3, and changes in the corrected QT interval (delta QTc) were examined in 22 patients during long-term treatment with amiodarone. At 1, 3, and 6 months of follow-up, the correlation coefficient between serum levels of amiodarone or desethylamiodarone and reverse T3 ranged from 0.01 to -0.2 (p greater than 0.4). At the same time intervals, the correlation coefficient between both amiodarone and desethylamiodarone levels and delta QTc ranged from 0.1 to -0.1 (p greater than 0.6), and the correlation coefficient between reverse T3 and delta QTc also ranged between 0.1 to -0.1 (p greater than 0.5). Substituting percent delta QTc for delta QTc also did not reveal a significant correlation. These data demonstrate that serum levels of reverse T3 cannot be used as a substitute for serum levels of amiodarone in monitoring patients being treated with amiodarone. The absence of a correlation between serum reverse T3 levels and delta QTc suggests that the delay in repolarization which occurs during amiodarone therapy is not secondary to an amiodarone-induced abnormality in thyroid hormone metabolism.lld:pubmed
pubmed-article:3953386pubmed:languageenglld:pubmed
pubmed-article:3953386pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3953386pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3953386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3953386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3953386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3953386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3953386pubmed:statusMEDLINElld:pubmed
pubmed-article:3953386pubmed:monthAprlld:pubmed
pubmed-article:3953386pubmed:issn0002-8703lld:pubmed
pubmed-article:3953386pubmed:authorpubmed-author:MoradyFFlld:pubmed
pubmed-article:3953386pubmed:authorpubmed-author:NicklasJ MJMlld:pubmed
pubmed-article:3953386pubmed:authorpubmed-author:CreveyB JBJlld:pubmed
pubmed-article:3953386pubmed:authorpubmed-author:FoleyM KMKlld:pubmed
pubmed-article:3953386pubmed:authorpubmed-author:BaermanJ MJMlld:pubmed
pubmed-article:3953386pubmed:authorpubmed-author:AnnesleyTTlld:pubmed
pubmed-article:3953386pubmed:authorpubmed-author:DiCarloL...lld:pubmed
pubmed-article:3953386pubmed:issnTypePrintlld:pubmed
pubmed-article:3953386pubmed:volume111lld:pubmed
pubmed-article:3953386pubmed:ownerNLMlld:pubmed
pubmed-article:3953386pubmed:authorsCompleteYlld:pubmed
pubmed-article:3953386pubmed:pagination644-8lld:pubmed
pubmed-article:3953386pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:meshHeadingpubmed-meshheading:3953386-...lld:pubmed
pubmed-article:3953386pubmed:year1986lld:pubmed
pubmed-article:3953386pubmed:articleTitleInterrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.lld:pubmed
pubmed-article:3953386pubmed:publicationTypeJournal Articlelld:pubmed